Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Eduardas, Aleknavičius"'
Autor:
Elona Juozaitytė, Eduardas Aleknavičius, Rasa Jančiauskienė, Alvydas Česas, Teresė Pipirienė-Želvienė, Sigita Liutkauskienė, Aurelija Krasauskienė, Lina Vencevičienė
Publikováno v:
Medicina, Vol 50, Iss 4, Pp 197-203 (2014)
The aim of this article is to inform about cancer treatment-induced bone loss, to identify patients at risk and those that can benefit from bone targeted treatment as well as highlight the importance of the multidisciplinary approach in the bone heal
Externí odkaz:
https://doaj.org/article/58e3aab744ce4841b4432dff97f9ff53
Publikováno v:
Medicina, Vol 50, Iss 4, Pp 230-236 (2014)
Background and objective: The internal mammary lymph nodes (IMN) have been recognized as a potential site of regional breast cancer spread. The aim of this study was to evaluate the impact of internal mammary node radiotherapy (RT) to on clinical out
Externí odkaz:
https://doaj.org/article/390cf0c8ef994ebfa0dc2fa961494437
Publikováno v:
Medicina, Vol 50, Iss 4, Pp 245-248 (2014)
Cetuximab (CTX) is used for the concurrent treatment with radiotherapy (RT) in squamous cell carcinoma of head and neck (HNSCC). There are no reliable clinical predictive markers of effectiveness of CTX at yet. We describe the clinical case of patien
Externí odkaz:
https://doaj.org/article/419e7c3c26c14c29846c852260949f13
Autor:
Lina Daukantienė, Birutė Kazbarienė, Konstantinas Povilas Valuckas, Janina Didžiapetrienė, Aurelija Krikštaponienė, Eduardas Aleknavičius
Publikováno v:
Medicina, Vol 50, Iss 4, Pp 222-229 (2014)
Background and objective: To determine changes in reduced glutathione (GSH) and glutathione S-transferase (GST) during neoadjuvant chemotherapy followed by concurrent chemoradiation for patients with stage IIB–IIIB cervical cancer, and to evaluate
Externí odkaz:
https://doaj.org/article/bcc64faff7154c2d8d1f3fe11b87a871
Autor:
Edita Baltruškevičienė, Ugnius Mickys, Tadas Žvirblis, Rokas Stulpinas, Teresė Pipirienė Želvienė, Eduardas Aleknavičius
Publikováno v:
Acta Medica Lituanica, Vol 23, Iss 1 (2016)
Background. KRAS mutation is an important predictive and prognostic factor for patients receiving anti-EGFR therapy. An expanded KRAS, NRAS, BRAF, PIK3CA mutation analysis provides additional prognostic information, but its role in predicting bevaciz
Externí odkaz:
https://doaj.org/article/fa17ed972dde4cf8b35599e9f3dcaf34
Autor:
Jūratė Liutkutė, Nadežda Lachej, Laura Steponavičienė, Teresė Pipirienė Želvienė, Eduardas Aleknavičius
Publikováno v:
Acta Medica Lituanica, Vol 22, Iss 1 (2015)
Įvadas. Vyrų krūties vėžys – reta onkologinė liga. Pasaulyje vyrai sudaro apie 1 % visų sergančiųjų krūties vėžiu. Lietuvos vėžio registro duomenimis, kasmet Lietuvoje nustatoma 10–14 naujų vyrų krūties vėžio atvejų. Medžia
Externí odkaz:
https://doaj.org/article/bee869bfb2774577823e6f0fed550ae0
Autor:
Lina Daukantienė, Konstantinas Povilas Valuckas, Eduardas Aleknavičius, Teresė Pipirienė-Želvienė
Publikováno v:
Lietuvos Chirurgija, Vol 12, Iss 3 (2013)
The purpose of this article is overview of currently available knowledge found in literature about the chemoradiation for locally advanced cervical cancer. Cervical cancer is the third most commonly diagnosed cancer and the fourth leading cause of ca
Externí odkaz:
https://doaj.org/article/bc0a06a7537a49c29161f3f217c05d95
Autor:
Elona, Juozaitytė, Eduardas, Aleknavičius, Rasa, Jančiauskienė, Alvydas, Cesas, Teresė, Pipirienė-Želvienė, Sigita, Liutkauskienė, Aurelija, Krasauskienė, Lina, Vencevičienė
Publikováno v:
Medicina (Kaunas, Lithuania). 50(4)
The aim of this article is to inform about cancer treatment-induced bone loss, to identify patients at risk and those that can benefit from bone targeted treatment as well as highlight the importance of the multidisciplinary approach in the bone heal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bcaeac5e2640bf3cd2010e0b20e84ca5
https://pubmed.ncbi.nlm.nih.gov/25458955
https://pubmed.ncbi.nlm.nih.gov/25458955
Autor:
Monika, Drobnienė, Audronė, Cicėnienė, Teresė Pipirienė, Zelvienė, Rūta, Grigienė, Nadežda, Lachej, Laura, Steponavičienė, Eduardas, Aleknavičius
Publikováno v:
Medicina (Kaunas, Lithuania). 47(9)
A case of successful and prolonged treatment of metastatic non-small cell lung cancer with the epidermal growth factor receptor antagonist erlotinib is presented. A never-smoker female was diagnosed with stage IV lung cancer in December 2005. A chest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f7d95261afa3db08003743a6ee329d5f
https://pubmed.ncbi.nlm.nih.gov/22156604
https://pubmed.ncbi.nlm.nih.gov/22156604
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.